US Tariffs on Pharmaceutical Products from Guyana โ 10% (2026)
Tariff Rate Breakdown
Pharmaceutical Products from Guyana represent an important segment of bilateral trade, with approximately $3B in total bilateral trade.
The current tariff framework for pharmaceutical products from Guyana reflects the post-SCOTUS landscape: a 10% Section 122 tariff replaced the previously higher IEEPA rates after the Court's February 2026 ruling.
The Section 122 tariff is subject to a 150-day statutory time limit and is set to expire approximately July 24, 2026, unless Congress acts to extend or replace it. Importers should monitor legislative developments closely as this deadline approaches.
Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, with the Section 122 tariff as the primary duty. No additional Section 232 or Section 301 surcharges apply to most products in this category from Guyana.
Key products in HTS Chapter 30 imported from Guyana include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.
Common Products in Chapter 30
Calculate Your Import Duty
Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from Guyana.
Open Tariff CalculatorFrequently Asked Questions
What is the current tariff rate on pharmaceutical products from Guyana?
Will the tariff on pharmaceutical products from Guyana change?
How did the Supreme Court ruling affect pharmaceutical products imports from Guyana?
Pharmaceutical Products Tariffs from Other Countries
Other Product Categories from Guyana
Specific HTS Codes in Chapter 30
Related Pages
Tariff rates change fast. Stay ahead.
Free alerts when US import tariff rates change. Join importers and trade professionals who stay informed.
No spam. Unsubscribe anytime.
